Publikasi

BIO 2026: To restore trust in vaccines, listen to every...

Listening to people’s concerns about vaccines is key to helping them regain trus...

Future of MP Pharma lies in quality manufacturing, expo...

Madhya Pradesh is steadily emerging as a pharma manufacturing hub. How do you a...

Aluminum Handrail System

Interna-Rail® aluminum handrail systems from Hollaender feature in-line fittings...

What are the risks of choosing not to implement complex...

Ian Gordon explains the clinical rationale, operational reality and practical ri...

FDD Leadership Awards spotlight FR&D excellence 

Continuing its tradition of recognising excellence, the FDD Leadership Awards 2...

India’s online pharmacy boom and the perils of unregula...

Online shopping has trained us to value one thing above all others: visibility....

Just Getting Started with the MCAT? This Beginner’s Gui...

Overwhelmed? You’re Not Alone When you first decide to take the MCAT, it’s easy ...

The quest to keep organs alive outside the body

This week, I covered a fascinating effort to preserve organs outside the body. T...

Colorectal Cancer Targeted with Mass-Produced iPSC-Deri...

Researchers generated off-the-shelf, mass-producible iPSC-derived allogeneic γδT...

Oral Antiviral Blocks Measles-Like Virus Transmission i...

An oral antiviral candidate prevented airborne and contact transmission of a mea...

Will your workplace group chat become your downfall?

Chris Barrow highlights why practice owners should take caution with casual out-...

How AI is redefining India’s pharmaceutical export edge

India’s pharmaceutical industry has gained an international reputation due to i...

FDD Conclave 2026: Charting the future of formulation s...

The pharma industry is entering an era where scientific innovation must move fa...

BIO 2026: Realizing the promise of CAR-T cell therapies

“CAR-T cell therapies are remarkable drugs and are the gold standard for patient...

FDA grants fast track designation for Lundbeck’s Lu AH6...

Lu AH69593 is an oral, small-molecule agonist of the orexin 2 receptor (OX2R). T...

BeOne to invest $300m in US manufacturing facility expa...

The new investment increases BeOne Medicines’ total spend on US manufacturing fa...